The patient presented with fulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with trimethoprim-sulfamethoxazole.
thrombocytopenia
sulfamethoxazole
thrombocytopenia
trimethoprim
fulminant microangiopathic hemolytic anemia
sulfamethoxazole
fulminant microangiopathic hemolytic anemia
trimethoprim